After a busy few weeks of news about Merck ‘s cancer-drug pipeline, the pharmaceutical company will announce its quarterly financial results on Thursday.
Wall Street analysts expect Merck to report earnings of $1.95 per share for the third quarter, up from $1.85 in the same quarter last year, according to FactSet. They expect sales of $15.3 billion, compared with $15 billion a year earlier. Also last week, Merck disclosed positive data from a number of trials, many involving Keytruda, its megablockbuster cancer immunotherapy. One Merck presentation, saying overall survival was increased by half in patients with urothelial cancer who received Keytruda in combination with the Seagen and Astellas Pharma drug Padcev, “earned a standing ovation,” according to a note from Goldman Sachs analyst Chris Shibutani.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Trading Earnings Season: 3 Steps for Using Earnings ReportsLearn how to trade earnings season, with tips on choosing companies and researching market conditions to establishing a strategy.
और पढो »
Stock Market News Today: Nasdaq Falls 300 Points; Alphabet Stock Price Falls After EarningsLive updates on what's moving markets, including stocks the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite
और पढो »
IBM's stock rises after earnings beat, company says AI adoption is growing‘Clients are increasingly adopting our watsonx AI and data platform along with our hybrid cloud solutions,’ CEO says
और पढो »
Boeing Posts Another Earnings Miss: What’s Next for the Stock?Stocks Analysis by The Tokenist (Timothy Fries) covering: Boeing Co, Boeing Comp, Boeing Co BDR, Boeing Co BA. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
और पढो »
Hilton beat earnings expectations and sees ‘meaningful uptick’ in openings, but stock fallsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
और पढो »
General Dynamics stock set to snap longest losing streak in 4 years after earnings beat expectationsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
और पढो »